172 related articles for article (PubMed ID: 33586444)
1. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
2. In vitro/in vivo evaluation of pH-sensitive Gambogenic acid loaded Zein nanoparticles with polydopamine coating.
Zha L; Qian J; Wang B; Liu H; Zhang C; Dong Q; Chen W; Hong L
Int J Pharm; 2020 Sep; 587():119665. PubMed ID: 32702449
[TBL] [Abstract][Full Text] [Related]
3. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
4. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
5. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
[TBL] [Abstract][Full Text] [Related]
6. Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Cheng W; Wang B; Zhang C; Dong Q; Qian J; Zha L; Chen W; Hong L
J Pharm Pharmacol; 2019 Nov; 71(11):1626-1634. PubMed ID: 31468524
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation.
Lin TY; Chang JL; Xun Y; Zhao Y; Peng W; Yang W; Ding BJ; Chen WD
Kaohsiung J Med Sci; 2020 May; 36(5):344-353. PubMed ID: 32293112
[TBL] [Abstract][Full Text] [Related]
8. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
11. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
12. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
14. A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.
Zhou Y; Zhu X; Lin S; Zhu C; Wu L; Chen R; Chen Z; Li W
Int J Nanomedicine; 2020; 15():5073-5082. PubMed ID: 32764937
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles.
Yan S; Huang Q; Chen J; Song X; Chen Z; Huang M; Xu P; Zhang J
Int J Nanomedicine; 2019; 14():6799-6812. PubMed ID: 31692522
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled micelles based on gambogenic acid-phospholipid complex for sustained-release drug delivery.
Wang B; Cheng W; Zhang C; Bao Y; Zha L; Qian J; Hong L; Chen W
J Microencapsul; 2019 Sep; 36(6):566-575. PubMed ID: 31411510
[No Abstract] [Full Text] [Related]
17. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
18. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Gambogenic Acid.
Huang P; Yang LL; Wang CY; Chen JP; Wang SS; Wang SJ; Chen YJ; Wang DL; Huang HP
J Nanosci Nanotechnol; 2015 Jul; 15(7):4774-83. PubMed ID: 26373037
[TBL] [Abstract][Full Text] [Related]
20. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
